Details

Autor(en) / Beteiligte

• Jiang, B
• Lyu, F N
• Zheng, X Y
• Cao, Y
• Mi, Y Q

Titel

Potential clinical value of new type of HBV serological markers ranking in the review column

Ist Teil von

• Zhonghua gan zang bing za zhi, 2020-08, Vol.28 (8), p.711

Ort / Verlag

China

Erscheinungsjahr

2020

Quelle

MEDLINE

Beschreibungen/Notizen

• Liver fibrosis, liver cirrhosis and hepatocellular carcinoma caused by chronic hepatitis B are still the main diseases that seriously affect the health of Chinese population. Notably, even if serum HBV-DNA cannot be detected after treatment, many patients will still develop liver disease. Therefore, in addition to the quantitative analysis of HBV-DNA and HBsAg, other new serological markers should be sought to facilitate the selection of CHB antiviral drugs and methods, monitoring efficacy and follow-up, efficacy prediction, and the risks of viral rebound after drug withdrawal. This article focuses on three new serological markers, namely HBcrAg, HBV-RNA and anti-HBc, with a view to applying them in clinical practice.